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A novel RHCE allele was identified in a 53-year-old African-
American female blood donor with an Rh phenotype of D+ C– 
E– c+ e+ and a negative antibody screen. The donor’s cells typed 
e+ with all antisera tested. By gel-based genotyping and cDNA 
analysis, the two RHCE alleles in this donor were characterized. 
One allele was found to be the known allele RHCE*01.20.01 




A novel RHCE allele, RHCE*ce254G,733G, was identified 
in a 53-year-old African-American female blood donor with 
an Rh phenotype of D+ C– E– c+ e+ and a negative antibody 
screen. The donor’s cells typed e+ with all antisera tested. 
The anti-e reagents tested were Seraclone (formulated from 
clones MS16/MS21/MS63) (Bio-Rad Laboratories, Hercules, 
CA), BioClone (formulated from MS16 clone) (Ortho Clinical 
Diagnostics, Rochester, NY), Immucor Series 1 (formulated 
from MS16 clone), and Immucor Gamma-clone (formulated 
from clones MS16/21/63) (Norcross, GA). The hrB status was 
not assessed serologically.
Materials and Methods
Genomic DNA from the donor was isolated from white 
blood cells using the QIAamp DNA Blood mini kit (Qiagen, 
Hilden, Germany) and was used for genotyping of the RHD and 
RHCE genes using laboratory-developed gel-based genotyping 
assays including a multiplex RH polymerase chain reaction 
(PCR) to detect RHD intron 7, exon 4, RHD pseudogene and 
RHCE expressing the C or c antigens, restriction fragment-
length polymorphism (RFLP) PCR, and sequence-specific 
primer (SSP) PCR. Red cell RNA isolation was performed 
by a laboratory-developed phenol-chloroform extraction and 
isopropanol precipitation method, cDNA synthesis with a 
Superscript III Synthesis kit (Life Technologies, Carlsbad, 
CA), reverse transcription–PCR amplification using Taq 
polymerase (Qiagen), and PCR product cloning with a TOPO 
TA cloning kit (Life Technologies). cDNA sequence analysis 
(cDNA seq) was performed (BigDye Terminator Kit, Life 
Technologies) using vector-based primers and compared with 
the consensus sequence using Sequencher 5.0 (GeneCodes 
Corporation, Ann Arbor, MI).
Results
A variety of gel-based genotyping assays were used 
to screen the donor sample for known single nucleotide 
polymorphisms (SNPs). The results are summarized in 
Table 1. cDNA analysis was performed to further characterize 
the two RHCE alleles to rule out the presence of additional 
variants. One allele was found to be known: RHCE*01.20.01 
(RHCE*ce733G). The second allele has not been reported 
previously; it carries two SNPs: RHCE c.254G and c.733G. 
The allele was named RHCE*ce254G,733G (Table 2) based on 
the ISBT allele terminology.1
Table 1. RH genotyping results 
Gene or  




RHD Intron 4 present 5




PCR Hybrid Rhesus box absent 6
RHD Exon 3 SSP 455A>C (N152T) A 7
RHD Exon 5
RFLP 667T>G (F223V) T 7
RFLP 697G>C or A (E233Q or E233K) G 7
RHD Exon 8 RFLP 1136C>T (T379M) C 8
RHCE Exon 1 RFLP 48G>C (W16C) G 9
RHCE Exon 2 RFLP 254C>G (A85G) C/G 10
RHCE Exon 5
RFLP 676G>C (A226P) G 11
RFLP 733C>G (L245V) G 12
RHCE Exon 7
SSP 1006G>T (G336C) G 12
RFLP 1025C>T (T342I) C 13
RHCE
cDNA seq cDNA 733G  (plasmid type 1) 14
254G, 733G 
(plasmid type 2)
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Additional Information
This case was the topic of a poster at the International 
Society of Blood Transfusion International Congress.2 As per 
the National Center for Biotechnology Information,3 the minor 
allele frequency of RHCE c.254G and c.733G are 0.0078 and 
0.0680, respectively. The frequency of the newly identified 
allele RHCE*ce254G,733G is unknown, but, based on the 
frequency of the two SNPs, is expected to be rare. RFLP-
PCR with HaeII can be used to interrogate RHCE c.254 for 
the presence of the variant.4 Although the phenotype encoded 
by this allele has not been fully investigated, it is noteworthy 
that the RHCE*01.06 allele with only c.254G encodes a partial 
e antigen and an RH:−59 (CEAG–) and RH:−31 (hrB–) 
phenotype.
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